Co-Diagnostics Cash Conversion Cycle 2011-2026 | CODX

Annual Cash Conversion Cycle Co-Diagnostics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-2.46 K	-352	299	321	200	222	844	-4.96 K	-38.4 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
844	-38.4 K	-4.92 K

Quarterly Cash Conversion Cycle Co-Diagnostics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-1.51 K	-3 K	-7.89 K	-	-149	-	-	-	1.12 K	1.62 K	1.27 K	-	611	684	156	-	127	210	235	-	167	159	1.08 K	-	1.15 K	644	8.04 K	-	126	126	63.1	-	-9.59 K	-9.59 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.04 K	-9.59 K	-590

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	51.8	$ 19.5	7.5 %	$ 600 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Castle Biosciences CSTL	31.6	$ 21.6	5.93 %	$ 626 M	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	2.11	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	79.6	$ 133.06	4.75 %	$ 16.7 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	52.5	$ 152.8	6.18 %	$ 12 B	Irlanda
CareDx, Inc CDNA	51.5	$ 23.12	3.63 %	$ 1.23 B	USA
Illumina ILMN	147	$ 168.06	-1.68 %	$ 26 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Interpace Biosciences IDXG	62.9	$ 1.79	2.29 %	$ 7.92 M	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Mettler-Toledo International MTD	66.4	-	-	$ 24.3 B	Schweiz
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	97.3	-	-	$ 6.94 B	USA
NeoGenomics NEO	82.4	$ 11.31	11.54 %	$ 1.45 B	USA
Charles River Laboratories International CRL	65	$ 185.79	3.29 %	$ 9.21 B	USA
Natera NTRA	48.3	$ 222.1	4.84 %	$ 30.4 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	50.4	$ 458.69	1.75 %	$ 13.2 B	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
National Research Corporation NRC	29.4	$ 19.75	3.73 %	$ 442 M	USA
Myriad Genetics MYGN	49.3	$ 4.69	6.59 %	$ 434 M	USA
Personalis PSNL	-1.89	$ 12.1	12.24 %	$ 1.08 B	USA
Koninklijke Philips N.V. PHG	89	$ 25.99	2.52 %	$ 24.6 B	Niderland
Senseonics Holdings SENS	36.1	$ 7.01	4.32 %	$ 293 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	-398	-	-	$ 2.69 B	USA
Biomerica BMRA	172	-	-	$ 4.94 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 260.97	0.79 %	$ 21.7 B	USA
Twist Bioscience Corporation TWST	83.6	-	-	$ 4.42 B	USA
Thermo Fisher Scientific TMO	70	$ 482.03	1.7 %	$ 182 B	USA
Trinity Biotech plc TRIB	136	$ 0.68	-2.4 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	150	$ 9.12	3.52 %	$ 1.98 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 196.12	1.27 %	$ 21.8 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Waters Corporation WAT	731	$ 376.47	-0.87 %	$ 22.4 B	USA